Biotech

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 16) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL) Eli Lilly And Co (NYSE: LLY) Inspire Medical Systems Inc (NYSE: INSP) Masimo Corporation (NASDAQ:...

The best kind of analyst downgrade for investors is the one that comes because a stock has performed so well that it has exceeded expectations. On Thursday, AstraZeneca plc (ADR) (NYSE: AZN) was hit with just such a downgrade. The Analyst Jefferies analyst Ian Hilliker downgraded AstraZeneca from...

Here's a roundup of top developments in the biotech space over the last 24 hours.  Scaling the Peaks (Stocks hitting 52-week highs on Aug. 15) Inspire Medical Systems Inc (NYSE: INSP) Merck & Co., Inc. (NYSE: MRK) Pacira Pharmaceuticals Inc (NASDAQ: PCRX) Down In The Dumps (Stocks...

Following the 90-percent year-to-date appreciation in Intercept Pharmaceutical, Inc. (NASDAQ: ICPT) shares, RBC Capital Markets considers the stock's risk-reward to be balanced.  The Analyst RBC Capital Markets analyst Brian Abrahams downgraded Intercept from Outperform to Sector...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 14) DexCom, Inc. (NASDAQ: DXCM) Masimo Corporation (NASDAQ: MASI) Medtronic PLC (NYSE: MDT) SurModics, Inc. (NASDAQ: SRDX) Xeris Pharmaceuticals Inc (NASDAQ...

Biotech Replimune Group, Inc. (NASDAQ: REPL), which conducts research and cancer treatment studies using oncolytic viruses, picked up a sell-side bull Tuesday. The Analyst BMO Capital Markets analyst Do Kim initiated coverage of Replimune Group with an Outperform rating and $31 price target. The...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 13) Iradimed Corp (NASDAQ: IRMD) SurModics, Inc. (NASDAQ: SRDX) Down In The Dumps (Stocks hitting 52-week lows on Aug. 13) Acasti Pharma (NASDAQ: ACST)...

The FDA recently approved Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)'s patisiran for polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. The genetic, often lethal, disease leads to abnormal buildup of amyloid protein in peripheral nerves, heart and other...

It’s been an eventful few weeks in the cannabis market. Then again, is it ever not eventful in cannabis? Between Tilray Inc (NASDAQ: TLRY) IPOing to become the first cannabis-producing company on a major American exchange, Aurora Cannabis’ (OTC: ACBFF) $2.5 billion acquisition of...

Below is a list of notable corporate events for the week beginning August 13. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences KeyBanc Capital Markets Global Technology Leadership Forum August 12-14 Notable Earnings Sysco Corporation...

The development-stage biotechnology company Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) uses protein interaction to treat myelofibrosis, in addition to addressing prostate cancer and other tumors. The Analysts Oppenheimer analyst Leah Rush Cann initiated coverage of ...

Sorrento Therapeutics Inc (NASDAQ: SRNE) shares were rallying Monday following the announcement of positive trial results for its osteoarthritis knee pain treatment candidate. In pre-market trading, the stock was trading up 3.7 percent to $5.60. Shares were down 0.46 percent at $5.38...

The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) has experienced volatility amid the release of another spate of earnings reports.  Even as the earnings season winds down, the upcoming week presents a slew of catalysts for biotech investors to watch.  Conferences 33rd...

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. Aridis Pharmaceuticals, Inc. (ARDS) will issue 2 million shares between $13 and $15 Tuesday on the Nasdaq. Based in California, the biotech firm develops therapies for antibiotic-resistant infections, including...

On Friday, TherapeuticsMD Inc (NASDAQ: TXMD) announced FDA approval of the first-ever patient-controlled long-acting reversible vaginal birth control system. What Happened? The FDA approved TherapeuticsMD’s ANNOVERA prescription birth control ring, which is inserted into the vagina and...